Shalby
add_icon

Shalby

154.33
-2.59
(-1.65%)
Market Cap
1,666.91 Cr
PE Ratio
45.35
Volume
50,336.00
Day High - Low
157.79 - 153.50
52W High-Low
274.70 - 125.82
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,666.91 Cr
EPS
3.23
PE Ratio
45.35
PB Ratio
1.69
Book Value
93.11
EBITDA
169.50
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
3.45
Debt to Equity
0.54
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Deepak Anand steps down as CEO of Shalby Medtech Limited effective September 4, 2026, citing personal reasons to move abroad. Shalby Limited confirmed no other material reasons for the exit.
neutral
Shalby Limited filed its Business Responsibility & Sustainability Report for FY26, detailing energy efficiency gains and CSR spending of ₹32.18 million.
neutral
Shalby Limited has convened its 22nd Annual General Meeting on September 10, 2026 via video conferencing, with key agenda items including adoption of FY26 financials and appointment of Shanay Vikram Shah as Whole-Time Director.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,800.00
#1 1,26,530.50
58.19
#1 25,420.10
15.58
#1 2,003
38.41
50.24
1,009.00
98,200.30
67.60
8,536.10
18.82
1,442
4.87
40.13
915.65
69,127.74
64.74
9,178.50
16.93
1,064
2.25
45.21
1,508.90
40,569.46
71.12
4,508.90
19.56
554
-1.07
67.57
754.80
39,107.78
183.22
4,643.22
8.32
384
-68.70
33.80
1,903.80
38,906.21
47.15
7,996.30
#1 43.43
811
5.39
52.63
768.45
32,275.40
163.30
3,930.80
28.16
242
-56.00
40.00
496.65
15,742.96
85.33
2,080.08
18.39
168
#1 44.36
47.36
1,441.00
14,634.67
50.68
1,746.90
11.49
282
16.17
42.02
290.15
12,532.47
#1 42.14
1,679.36
17.77
272
35.27
58.24

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
4.81 %
Net Income Growth
1,726.32 %
Cash Flow Change
99.77 %
ROE
1,715.79 %
ROCE
4.10 %
EBITDA Margin (Avg.)
0.97 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
91
119
122
115
116
133
128
123
119
41
118
134
147
195
184
165
167
206
207
207
208
240
243
221
249
289
275
281
270
303
290
279
296
339
Expenses
64
91
97
93
98
102
98
99
106
43
86
101
114
154
152
139
139
162
165
169
173
192
185
174
205
234
235
242
244
255
244
242
258
290
EBITDA
27
27
25
22
17
31
30
24
13
-3
32
33
33
41
32
27
28
44
42
38
35
48
58
47
44
55
40
39
26
49
46
38
37
49
Operating Profit %
29 %
21 %
19 %
17 %
13 %
22 %
22 %
18 %
2 %
-13 %
26 %
23 %
21 %
20 %
16 %
15 %
15 %
20 %
18 %
17 %
13 %
18 %
22 %
20 %
16 %
16 %
12 %
12 %
8 %
14 %
15 %
11 %
10 %
13 %
Depreciation
4
8
8
9
8
9
9
9
9
9
9
9
9
9
12
11
11
12
12
12
13
12
12
12
16
16
17
16
16
17
17
18
19
19
Interest
4
2
2
2
3
1
1
2
2
1
1
1
1
1
2
2
2
2
2
3
3
3
3
4
7
8
9
11
11
9
10
11
9
11
Profit Before Tax
19
18
15
12
7
21
20
14
2
-13
22
23
23
31
19
14
15
31
29
24
19
33
43
31
22
30
14
12
-1
23
19
9
10
20
Tax
4
6
11
-2
4
-3
7
6
19
-4
-3
6
13
11
8
1
5
11
10
8
5
12
15
12
6
16
11
15
11
15
12
8
-9
9
Net Profit
15
12
4
13
3
24
13
8
-17
-9
25
17
10
20
11
13
10
20
18
15
14
21
28
19
16
15
2
-3
-12
8
7
1
19
11
EPS in ₹
1.63
1.11
0.33
1.24
0.30
2.19
1.20
0.75
-1.58
-0.81
2.27
1.56
0.91
1.87
0.99
1.20
0.94
1.87
1.71
1.42
1.29
1.94
2.57
1.78
1.49
1.37
0.22
-0.28
-1.13
0.71
0.68
0.12
1.72
0.98

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
679
961
939
967
997
1,194
1,281
1,608
1,704
1,839
Fixed Assets
323
650
692
673
660
675
685
966
955
1,046
Current Assets
89
212
197
234
271
451
517
552
658
719
Capital Work in Progress
221
47
3
6
8
6
11
15
22
19
Investments
0
0
11
28
16
25
146
81
95
62
Other Assets
135
264
233
260
314
488
440
545
632
712
Total Equity & Liabilities
679
961
939
967
997
1,194
1,281
1,608
1,704
1,839
Current Liabilities
130
115
88
83
82
173
194
323
455
576
Non Current Liabilities
298
95
71
84
80
145
159
277
253
258
Total Equity
251
752
780
799
835
876
928
1,008
995
1,006
Reserve & Surplus
164
643
672
691
727
768
820
893
885
898
Share Capital
87
108
108
108
108
108
107
107
108
108

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
22
-19
3
0
-6
3
-2
49
-43
15
8
-13
Investing Activities
-62
-98
-153
-236
1
-31
-51
-60
-61
146
-36
-97
Operating Activities
123
5
61
14
43
55
79
19
68
20
-4
0
Financing Activities
-39
75
96
222
-51
-22
-30
91
-50
-151
48
84

Share Holding

% Holding
Mar 2021
May 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
79.45 %
74.07 %
74.07 %
74.02 %
74.02 %
74.02 %
74.04 %
74.04 %
74.12 %
74.12 %
74.12 %
74.12 %
74.12 %
74.24 %
74.25 %
74.25 %
74.27 %
74.27 %
74.27 %
74.33 %
74.33 %
74.33 %
74.33 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.11 %
4.62 %
4.88 %
5.35 %
5.37 %
4.65 %
4.54 %
5.20 %
4.64 %
4.47 %
4.36 %
4.46 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.09 %
0.14 %
0.18 %
0.20 %
0.20 %
0.20 %
0.25 %
0.30 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.68 %
11.97 %
11.14 %
11.16 %
12.03 %
11.86 %
11.91 %
11.95 %
11.06 %
11.13 %
11.28 %
11.35 %
10.66 %
10.40 %
9.97 %
10.09 %
10.78 %
10.67 %
11.20 %
11.74 %
11.73 %
11.52 %
12.12 %
Others
8.86 %
13.96 %
14.79 %
14.82 %
13.95 %
14.13 %
14.06 %
14.01 %
14.76 %
14.75 %
14.59 %
10.42 %
10.60 %
10.49 %
10.37 %
10.20 %
10.16 %
10.34 %
9.13 %
9.11 %
9.29 %
9.54 %
8.79 %
No of Share Holders
55,974
54,939
52,524
53,854
55,562
55,233
54,666
54,537
52,775
52,181
52,580
50,225
49,495
49,858
49,315
51,479
52,328
52,895
53,437
53,784
52,495
51,415
50,770

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.5 0.5 1 1 1.2 1.2 0.00 0.00
Dividend Yield (%) 0.00 0.00 1.08 0.5 0.85 0.77 0.5 0.61 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
10 Sept 2026 173.94 156.92
21 Sept 2021 DIVIDEND Dividend
1.00 /share
17 Sept 2021 133.15 183.10
21 Sept 2022 DIVIDEND Dividend
1.00 /share
19 Sept 2022 105.60 142.00
09 Aug 2023 DIVIDEND Dividend
1.20 /share
08 Aug 2023 148.65 198.70
20 Sept 2024 DIVIDEND Dividend
1.20 /share
19 Sept 2024 279.85 274.25
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 272.55 277.50
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 242.80 261.65
03 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2025 210.95 222.72
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 199.05 199.46
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 207.75 205.99
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 201.14 247.20
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 242.78 229.55
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 166.15 177.35
27 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2026 168.60 173.94
12 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2026 165.75 161.70

Announcements

Weblink Letter To Shareholders Whose Email Ids Are Not Registered Intimating Exact Path Of Annual Report FY 2025-26 And Notice Of 22Nd AGM7 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Announcement under Regulation 30 (LODR)-Change in Management9 days ago
Business Responsibility and Sustainability Reporting (BRSR)10 days ago
Reg. 34 (1) Annual Report.10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2026
Board Meeting Outcome for Outcome Of Board Meeting Of Financial Results For Quarter Ended June 30 2026Aug 12, 2026
Financial Results For Quarter Ended June 30 2026Aug 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 10, 2026
Availing Of Working Capital FacilitiesJul 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2026
Update on board meetingJul 27, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJul 27, 2026
Exercise Of Stock OptionJul 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026Jul 15, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJun 27, 2026
Closure of Trading WindowJun 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 05, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2026
UpdatesMay 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 27, 2026
Board Meeting Outcome for Outcome Of Board MeetingMay 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 18, 2026
Strike Off Of Step Down Subsidiary Ningen Lifecare Pvt. Ltd.May 14, 2026
Board Meeting Intimation for Approving Audited Financial Results (Standalone & Consolidated) For Quarter And Year Ended March 31 2026 Recommendation Of Dividend If Any And Other Business MattersMay 11, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 08, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 05, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 17, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2026
Intimation Of Receipt Of Approval For Kidney Transplant At Shalby Hospitals Krishna Unit-Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 11, 2026
Update On Pending Litigation - Order Passed By Statutory Authority (Disclosure Under Reg. 30 Of SEBI (LODR))Apr 11, 2026
Giving Guarantees/Indemnity/ Becoming A Surety For Third PartyApr 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2026
Closure of Trading WindowMar 25, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 23, 2026
Inauguration Of Oncology Department Along With Advanced Radiotherapy Facilities At Krishna Shalby HospitalMar 23, 2026
Disclosure Under Reg. 30 Of SEBI (LODR) Regulations 2015 - Major Development - Inauguration Of Oncology Department Along With Advanced Radiotherapy Facilities At Shalby Hospital SuratMar 09, 2026
NABH Accreditation To PK Healthcare Pvt Ltd. (Shalby International Hospitals) - Subsidiary CompanyMar 03, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-1
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.03%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
45.06
ATR(14)
Less Volatile
4.75
STOCH(9,6)
Neutral
36.00
STOCH RSI(14)
Neutral
72.76
MACD(12,26)
Bullish
0.16
ADX(14)
Strong Trend
29.32
UO(9)
Bearish
43.85
ROC(12)
Downtrend And Accelerating
-3.06
WillR(14)
Neutral
-58.12